Pavone, Luigi Michele;Paterno', Roberto;Avvedimento, Vittorio Enrico;Santillo, Mariarosaria
发明人:
申请号：
EP16176276.0
公开号：
EP3109257A1
申请日:
2016.06.24
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The serotonin receptor 5HT2A (5HT2aR) and membrane NADPH oxidases (NOX enzymes) are found to be a target of autoantibodies present in Multiple Sclerosis patients. The present invention refers to peptides comprised in the extracellular regions of the human 5HT2aR and/or NOXs for diagnosis and therapy of Multiple Sclerosis.
